Ameritas launches multi-year guaranteed annuity

Ameritas launched RateLock, a fixed annuity offering guaranteed interest rates for three-, five- and seven-year periods, with up to 10% of account value accessible annually without surrender charges, subject to contract terms. The launch expands the company’s retirement-savings lineup as U.S. annuity sales reached a record in Q2 2026, up 4% year over year, according to LIMRA.

Analysis

This is a product-level signal, not yet an earnings signal. The economic lever is the rate sheet: a compelling guaranteed rate could help Ameritas attract deposits from CDs and competing fixed annuities, but the release gives no actual rates, sales targets, or distribution data. Without those, “competitive” is a company claim rather than evidence of pricing power or likely market-share gains.

For insurers, MYGA growth is not unambiguously positive: the carrier locks in a multi-year liability and must earn enough on assets to support the guarantee, while preserving liquidity for permitted withdrawals. If market rates rise, new products may need higher credited rates and existing contracts can become less attractive, potentially increasing surrender pressure; if rates fall, existing guarantees may be valuable to buyers but reinvestment yields can compress asset-liability economics. The 10% annual access feature may help sales but also makes cash-flow behavior less predictable.

Near term, expect little investable read-through from a single launch. Over 1–3 months, rate competitiveness, agent adoption, and actual sales would matter more than the product announcement. Over 6–18 months, the key test is whether growth can be written at rates that sustain spreads through changing reinvestment conditions. No listed-company identity or contract rate is supplied, so there is no well-grounded single-name trade. The contrarian point: record category sales do not establish that incremental volume is profitable; competition for rate-sensitive flows can raise acquisition costs or pressure economics.

Key Decisions for Investors

• No trade on the launch alone. Treat it as a watch item for publicly traded life insurers with material fixed-annuity exposure, rather than inferring a direct equity catalyst for Ameritas.
• Request the three-, five-, and seven-year rate sheet, premium bands, commissions/distribution reach, surrender terms, and subsequent sales disclosures before judging whether the offer can take share without sacrificing spread economics.
• Over the next 1–3 months, monitor annuity sales and competitor rate changes alongside insurer commentary on new-business spreads and investment yields. Evidence of share gains paired with stable spreads would strengthen the positive read-through; rate-led sales with spread deterioration would falsify it.
• Key reversal risk over 6–18 months: a sustained rise in market rates that forces repricing or raises surrender activity, or falling reinvestment yields that compress returns on supporting assets. Avoid attributing category-wide sales growth to this product without company-specific evidence.